Valiant Laboratories is scheduled to hit the market on September 27, 2023 and close on October 3, 2023. Valiant Laboratories plans to raise around ₹152.46 Cr through an IPO with a sale of up to 10,890,000 equity shares of ₹10 each. The retail quota is 35%, QIB is 50%, and HNI is 15%.
Established in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing firm based in India, specializing in the production of Paracetamol. Situated in Palghar, Maharashtra, their manufacturing unit occupies 2,000 square meters of land and boasts an annual installed capacity of 9,000 metric tons.
Valiant Laboratories also houses an R&D Facility equipped with an analytical laboratory, enabling them to engage in developmental activities related to existing products.
Valiant Laboratories IPO Details
Valiant Laboratories IPO opens on Sept 27 2023, and closes on Oct 03, 2023. The Listing date for Valiant Laboratories IPO is on Oct 09, 2023. The price band for IPO is ₹133 to ₹140 per share and lot size of 105 Shares.
|IPO Date||Sept 27, 2023 to Oct 03, 2023|
|Listing Date||Oct 11, 2023|
|Price||₹133 to ₹140 per share|
|Lot Size||105 Shares|
|Issue Size||₹152.46 Cr|
|Face Value||₹10 per share|
Valiant Laboratories IPO Tentative Timetable
Valiant Laboratories opening date is September 27, 2023 and close date is October 3, 2023. The IPO allotment date is October 05, 2023. The refund initiation of IPO is on October 06, 2023. The credit of shares in demat account is on October 06, 2023. The listing date is on October 09, 2023.
|IPO Opening||Sept 27, 2023|
|IPO Closing||Oct 03, 2023|
|IPO Allotment Date||Oct 05 2023|
|Refund Initiation||Oct 06, 2023|
|Shares Credit to Demat||Oct 06, 2023|
|Lisiting Date||Oct 09, 2023|
Valiant Laboratories IPO Lot Size
Lot Size of this IPO is 105 shares. A retail-individual investor can apply for up to 13 lots (1365 shares or ₹191,100).
Valiant Laboratories IPO Promoter Holding
|Pre Issue Share Holding||100.00%|
|Post Issue Share Holding||74.94%|
Valiant Laboratories IPO Review
Valiant Laboratories Limited, a pharmaceutical ingredient manufacturing company based in India, is preparing for an initial public offering (IPO) with a fresh issue of 1.09 crore shares. The IPO is set to open for subscription on September 27, 2023, and close on October 3, 2023, with an expected listing date of October 9, 2023. The company is looking to list on both the BSE and NSE. Valiant Laboratories primarily focuses on manufacturing Paracetamol, a widely used pharmaceutical ingredient.
Key financial indicators such as Return on Equity (ROE) and Return on Capital Employed (ROCE) appear healthy, indicating the company’s profitability. Debt Levels: Valiant Laboratories has maintained a relatively low level of debt, with a Debt/Equity ratio of 0.59. The funds raised from the IPO will be used for investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL), which is involved in specialty chemicals manufacturing. It will also be used for working capital requirements and general corporate purposes.
As of April 30, 2023, Valiant Laboratories had 86 employees. The company imports Para Amino Phenol, a key raw material for Paracetamol manufacturing, from China and Cambodia. Investors considering participation in the Valiant Laboratories IPO should closely examine the IPO prospectus, especially once the price band is disclosed, to make an informed investment decision.
Valiant Laboratories IPO Subscription Status (Bidding Details)
|Qualified Institutions (QII)||0|
|bNII (bids above ₹10L)||0|
|sNII (bids below ₹10L)||0|
Valiant Laboratories IPO Broker Recommendations
- Capital Market: To be updated soon
- Anand Rathi: To be updated soon
- SMC Global: To be updated soon
- Arihant Capital: To be updated soon
Valiant Laboratories IPO FAQs
What is Valiant Laboratories IPO?
Valiant Laboratories is issuing 10,890,000 equity shares with a face value of ₹10 each, totaling up to ₹152.46 Cr. The shares are being offered at a price of ₹133 to ₹140 each, with a minimum order quantity of 105 Shares.
Link Intime India Private Ltd is the registrar for the IPO, and the shares are planned to be listed on the BSE and NSE.
When Valiant Laboratories IPO will open?
Valiant Laboratories will open on September 27, 2023 for QIB, NII, and Retail Investors.
When Valiant Laboratories IPO will end?
Valiant Laboratories will end on October 3, 2023.
What is Valiant Laboratories IPO Size?
Valiant Laboratories IPO size is ₹152.46 Cr.
What is Valiant Laboratories IPO Price Band?
Valiant Laboratories price band is ₹133 to ₹140.
What is the Valiant Laboratories IPO Allotment Date?
Valiant Laboratories allotment date is 05 October 2023.
What is the Valiant Laboratories IPO Listing Date?
Valiant Laboratories listing date is 09 October 2023. The IPO is to be listed on BSE and NSE.
How to Apply Valiant Laboratories IPO through Zerodha?
To apply for the IPO “Valiant Laboratories” on Zerodha, log in to the Zerodha website or app, go to the Portfolio section, and click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don’t have one, open a demat account with Zerodha.
How to Apply Valiant Laboratories IPO through Upstox?
To apply for the IPO “Valiant Laboratories” on Upstox, log in to the Upstox website or app, click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don’t have one, open a demat account with Upstox.
How to check Valiant Laboratories IPO Allotment Status?
For Valiant Laboratories IPO Allotment status check you can visit this link, select the desired IPO and enter your PAN to check the allotment status.
What is Valiant Laboratories IPO GMP?
You can check out here: Valiant Laboratories IPO GMP